Daiwa Securities Group’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.61M Buy
96,065
+2,500
+3% +$41.9K 0.01% 660
2025
Q1
$1.44M Buy
93,565
+600
+0.6% +$9.22K 0.01% 668
2024
Q4
$2.05M Buy
92,965
+3,500
+4% +$77.1K 0.01% 593
2024
Q3
$1.61M Buy
89,465
+8,100
+10% +$146K 0.01% 624
2024
Q2
$1.32M Sell
81,365
-34,328
-30% -$558K 0.01% 648
2024
Q1
$1.63M Buy
115,693
+4,170
+4% +$58.8K 0.01% 605
2023
Q4
$1.17M Sell
111,523
-13,921
-11% -$145K 0.01% 656
2023
Q3
$1.28M Sell
125,444
-758
-0.6% -$7.73K 0.01% 607
2023
Q2
$951K Sell
126,202
-3,645
-3% -$27.5K 0.01% 679
2023
Q1
$1.15M Buy
129,847
+12,033
+10% +$106K 0.01% 626
2022
Q4
$1.08M Sell
117,814
-2,411
-2% -$22K 0.01% 632
2022
Q3
$971K Sell
120,225
-17,624
-13% -$142K 0.01% 650
2022
Q2
$1.04M Sell
137,849
-17,446
-11% -$131K 0.01% 648
2022
Q1
$1.46M Buy
155,295
+18,693
+14% +$176K 0.01% 592
2021
Q4
$1.1M Sell
136,602
-11,053
-7% -$88.6K 0.01% 684
2021
Q3
$1.44M Buy
147,655
+11,753
+9% +$115K 0.01% 586
2021
Q2
$1.35M Buy
135,902
+9,330
+7% +$92.3K 0.01% 563
2021
Q1
$1.46M Sell
126,572
-9,233
-7% -$107K 0.01% 514
2020
Q4
$1.31M Sell
135,805
-35,763
-21% -$345K 0.01% 507
2020
Q3
$1.55M Sell
171,568
-27,472
-14% -$248K 0.01% 397
2020
Q2
$506K Hold
199,040
0.01% 533
2020
Q1
$1.79M Sell
199,040
-24,400
-11% -$219K 0.02% 345
2019
Q4
$2.19M Buy
223,440
+11,853
+6% +$116K 0.02% 336
2019
Q3
$1.46M Buy
211,587
+171,004
+421% +$1.18M 0.01% 411
2019
Q2
$375K Buy
40,583
+5,200
+15% +$48.1K ﹤0.01% 749
2019
Q1
$555K Sell
35,383
-41,410
-54% -$650K ﹤0.01% 612
2018
Q4
$1.19M Buy
76,793
+42,610
+125% +$658K 0.01% 411
2018
Q3
$736K Buy
34,183
+2,329
+7% +$50.1K 0.01% 553
2018
Q2
$775K Buy
31,854
+2,000
+7% +$48.7K 0.01% 538
2018
Q1
$3.07M Buy
29,854
+3,354
+13% +$345K 0.02% 303
2017
Q4
$502K Hold
26,500
﹤0.01% 612
2017
Q3
$466K Sell
26,500
-65,200
-71% -$1.15M ﹤0.01% 599
2017
Q2
$3.05M Buy
91,700
+13,600
+17% +$452K 0.02% 262
2017
Q1
$2.51M Sell
78,100
-11,200
-13% -$359K 0.02% 307
2016
Q4
$3.24M Buy
89,300
+34,300
+62% +$1.24M 0.02% 218
2016
Q3
$2.53M Buy
55,000
+51,848
+1,645% +$2.39M 0.02% 266
2016
Q2
$1.19M Buy
+3,152
New +$1.19M 0.01% 368